Skip to main content

. 1974 Feb;50(2):192–210.

Manifestations and management of ocular toxoplasmosis.

PMCID: PMC1749344 PMID: 4521729

195

Images in this article

Fig. 1
on p.193

Fig. 2
on p.196

Fig. 3
on p.204

Fig. 4
on p.205

Fig. 5
on p.206

Fig. 6
on p.207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ACERS T. E. TOXOPLASMIC RETINOCHOROIDITIS: A DOUBLE BLIND THERAPEUTIC STUDY. Arch Ophthalmol. 1964 Jan;71:58–62. doi: 10.1001/archopht.1964.00970010074010. [DOI] [PubMed] [Google Scholar]
Arrell R. W. Acute tuberculous panophthalmitis. Arch Ophthalmol. 1967 Jul;78(1):51–54. doi: 10.1001/archopht.1967.00980030053010. [DOI] [PubMed] [Google Scholar]
BERENGO A., FREZZOTTI R. Active neuro-ophthalmic toxoplasmosis. A clinical study on nineteen patients. Bibl Ophthalmol. 1962;59:265–343. [PubMed] [Google Scholar]
CHOI C. S. Penetration of pyrimethamine (daraprim) into ocular tissues of rabbits. AMA Arch Ophthalmol. 1958 Oct;60(4 Pt 1):603–611. doi: 10.1001/archopht.1958.00940080623008. [DOI] [PubMed] [Google Scholar]
Chesterton J. R., Perkins E. S. Ocular toxoplasmosis among Negro immigrants in London. Br J Ophthalmol. 1967 Sep;51(9):617–621. doi: 10.1136/bjo.51.9.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
Desmonts G. Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol. 1966 Dec;76(6):839–851. doi: 10.1001/archopht.1966.03850010841012. [DOI] [PubMed] [Google Scholar]
Dobbie J. G. Cryotherapy in the management of toxoplasma retinochoroiditis. Trans Am Acad Ophthalmol Otolaryngol. 1968 May-Jun;72(3):364–373. [PubMed] [Google Scholar]
Frenkel J. K. Adoptive immunity to intracellular infection. J Immunol. 1967 Jun;98(6):1309–1319. [PubMed] [Google Scholar]
Friedmann C. T., Knox D. L. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 1969 Apr;81(4):481–493. doi: 10.1001/archopht.1969.00990010483005. [DOI] [PubMed] [Google Scholar]
HEMSATH F. A., PINKERTON H. Disseminated cytomegalic inclusion disease and disseminated toxoplasmosis in an adult with myeloid metaplasia; report of a case. Am J Clin Pathol. 1956 Jan;26(1):36–41. doi: 10.1093/ajcp/26.1.36. [DOI] [PubMed] [Google Scholar]
HOGAN M. J., KIMURA S. J., O'CONNOR G. R. OCULAR TOXOPLASMOSIS. Arch Ophthalmol. 1964 Nov;72:592–600. doi: 10.1001/archopht.1964.00970020592003. [DOI] [PubMed] [Google Scholar]
HOGAN M. J., ZWEIGART P. A., LEWIS A. Recovery of toxoplasma from a human eye. AMA Arch Ophthalmol. 1958 Oct;60(4 Pt 1):548–554. doi: 10.1001/archopht.1958.00940080566004. [DOI] [PubMed] [Google Scholar]
MANSCHOT W. A., DAAMEN C. B. CONNATAL OCULAR TOXOPLASMOSIS. Arch Ophthalmol. 1965 Jul;74:48–54. doi: 10.1001/archopht.1965.00970040050012. [DOI] [PubMed] [Google Scholar]
McMaster P. R., Powers K. G., Finerty J. F., Lunde M. N. The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice. Am J Trop Med Hyg. 1973 Jan;22(1):14–17. doi: 10.4269/ajtmh.1973.22.14. [DOI] [PubMed] [Google Scholar]
O Connor G. R. The infleunce of hypersensitivity on the pathogenesis of ocular toxoplasmosis. Trans Am Ophthalmol Soc. 1970;68:501–547. [PMC free article] [PubMed] [Google Scholar]
O'CONNOR G. R. Precipitating antibody to toxoplasma; a follow-up study on findings in the blood and aqueous humor. Am J Ophthalmol. 1957 Oct;44(4 Pt 2):75–85. [PubMed] [Google Scholar]
O'CONNOR G. R., REMINGTON J. S. THERAPY OF TOXOPLASMIC RETINOCHOROIDITIS. Arch Ophthalmol. 1964 Jun;71:883–885. doi: 10.1001/archopht.1964.00970010899023. [DOI] [PubMed] [Google Scholar]
PILLAT A., THALHAMMER O. Herdförmige Iridocyclitis als (einzige) Manifestation einer erworbenen Toxoplasmose, ätiologisch gesichert durch Titerkurve und Tierversuch; zugleich ein Beitrag zur Diagnose des Alters einer Toxoplasmoseinfektion durch das, Diskepranzauswertungsverfahren und zur Art der Sabin-Feldmann- und Komplementbindungsreaktion reagierenden Antikörper. Albrecht Von Graefes Arch Ophthalmol. 1957;158(5):403–415. [PubMed] [Google Scholar]
Perkins E. S. Ocular toxoplasmosis. Br J Ophthalmol. 1973 Jan;57(1):1–17. doi: 10.1136/bjo.57.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
Piper R. C., Cole C. R., Shadduck J. A. Natural and experimental ocular toxoplasmosis in animals. Am J Ophthalmol. 1970 Apr;69(4):662–668. doi: 10.1016/0002-9394(70)91636-3. [DOI] [PubMed] [Google Scholar]
Remington J. S., Krahenbuhl J. L., Mendenhall J. W. A role for activated macrophages in resistance to infection with Toxoplasma. Infect Immun. 1972 Nov;6(5):829–834. doi: 10.1128/iai.6.5.829-834.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
SILVERSTEIN A. M., ZIMMERMAN L. E. Immunogenic endophthalmitis produced in the guinea pig by different pathogenetic mechanisms. Am J Ophthalmol. 1959 Nov;48(5):435–447. doi: 10.1016/0002-9394(59)90596-3. [DOI] [PubMed] [Google Scholar]
Spalter H. F., Campbell C. J., Noyori K. S., Rittler M. C., Koester C. J. Prophylactic photocoagulation of recurrent toxoplasmic retinochoroiditis. A preliminary report. Arch Ophthalmol. 1966 Jan;75(1):21–31. doi: 10.1001/archopht.1966.00970050023006. [DOI] [PubMed] [Google Scholar]
WILDER H. C. Toxoplasma chorioretinitis in adults. AMA Arch Ophthalmol. 1952 Aug;48(2):127–136. doi: 10.1001/archopht.1952.00920010132001. [DOI] [PubMed] [Google Scholar]
Wolf A., Cowen D., Paige B. HUMAN TOXOPLASMOSIS: OCCURRENCE IN INFANTS AS AN ENCEPHALOMYELITIS VERIFICATION BY TRANSMISSION TO ANIMALS. Science. 1939 Mar 10;89(2306):226–227. doi: 10.1126/science.89.2306.226. [DOI] [PubMed] [Google Scholar]
Work K. Resistance of Toxoplasma gondii encysted in pork. Acta Pathol Microbiol Scand. 1968;73(1):85–92. doi: 10.1111/j.1699-0463.1968.tb00482.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

PDF (4.2 MB)

RESOURCES